S. Kanatakis

The effect of adherence to therapy on sustained response in daily or three times a week interferon alpha‐2b plus ribavirin treatment of naïve and nonresponder chronic hepatitis C patients

M. Raptopoulou, D. Tsantoulas, I. Vafiadi et al. · Journal of Viral Hepatitis · 2005 · 37 citations

Pharmacy, Pharmacotherapy, Clinical Pharmacology +13

Natural course of treated and untreated chronic HCV infection: results of the nationwide <i>Hepnet</i>.<i>Greece</i> cohort study

Emanuel K. Manesis, George Papatheodoridis, Giota Touloumi et al. · Alimentary Pharmacology & Therapeutics · 2009 · 19 citations

Medicine, Infectious Diseases, Internal Medicine +15

Subclasses of antibodies to hepatitis B core antigen in chronic HBV infection: changes during treatment with alpha interferons and predictors of response.

Gabriel Hsu‐Chung Chen, Peter Karayiannis, Michael J. McGarvey et al. · Gut · 1989 · 14 citations · Full text

Life Sciences, Immunology, Infectious Diseases +9

A randomized trial to assess the efficacy of interferon alpha in combination with ribavirin in the treatment of interferon alpha nonresponders with chronic hepatitis C: superior efficacy of high daily dosage of interferon alpha in genotype 1

N.C. Tassopoulos, D. Tsantoulas, M. Raptopoulou et al. · Journal of Viral Hepatitis · 2003 · 12 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Anti-HBs response in seroconverting chronic HBV carriers following alpha-interferon treatment

Peter Karayiannis, S. Kanatakis, H. C. Thomas · Journal of Hepatology · 1990 · 10 citations

Life Sciences, Immunology, Infectious Diseases +14